Insider Trading Alert - MJN, IT And PXLW Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 2, 2014, 92 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $256.46 to $6,915,950.00.

Highlighted Stocks Traded by Insiders:

Mead Johnson Nutrition (MJN) - FREE Research Report

Singer Robert S, who is Director at Mead Johnson Nutrition, sold 3,000 shares at $89.27 on June 2, 2014. Following this transaction, the Director owned 18,676 shares meaning that the stake was reduced by 13.84% with the 3,000-share transaction.

The shares most recently traded at $89.39, up $0.12, or 0.13% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 29,062
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 49,062
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 99,766

The average volume for Mead Johnson Nutrition has been 1.4 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $18.1 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 7.07% year-to-date as of the close of trading on Monday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.68%. The company has a P/E ratio of 27.4. Currently, there are 6 analysts who rate Mead Johnson Nutrition a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Mead Johnson Nutrition Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Gartner (IT) - FREE Research Report

Kutnick Dale, who is Svp at Gartner, sold 13,198 shares at $70.90 on June 2, 2014. Following this transaction, the Svp owned 33,006 shares meaning that the stake was reduced by 28.56% with the 13,198-share transaction.

The shares most recently traded at $71.23, up $0.33, or 0.46% since the insider transaction. Historical insider transactions for Gartner go as follows:

  • 4-Week # shares sold: 3,680
  • 12-Week # shares sold: 14,225
  • 24-Week # shares sold: 26,271

The average volume for Gartner has been 499,600 shares per day over the past 30 days. Gartner has a market cap of $6.4 billion and is part of the technology sector and computer software & services industry. Shares are up 0.17% year-to-date as of the close of trading on Monday.

Gartner, Inc. provides independent and objective research and analysis on the information technology (IT), computer hardware, software, communications, and related technology industries in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company has a P/E ratio of 36.5. Currently, there are 4 analysts who rate Gartner a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IT - FREE

TheStreet Quant Ratings rates Gartner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Gartner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Pixelworks (PXLW) - FREE Research Report

Walicek Bruce A, who is President and CEO at Pixelworks, sold 20,556 shares at $6.24 on June 2, 2014. Following this transaction, the President and CEO owned 360,649 shares meaning that the stake was reduced by 5.39% with the 20,556-share transaction.

The shares most recently traded at $6.49, up $0.25, or 3.81% since the insider transaction. Historical insider transactions for Pixelworks go as follows:

  • 4-Week # shares bought: 5,014
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 5,014
  • 12-Week # shares sold: 81,966
  • 24-Week # shares bought: 5,014
  • 24-Week # shares sold: 146,044

The average volume for Pixelworks has been 1.9 million shares per day over the past 30 days. Pixelworks has a market cap of $140.0 million and is part of the technology sector and electronics industry. Shares are up 29.46% year-to-date as of the close of trading on Monday.

Pixelworks, Inc. designs, develops, and markets video and pixel processing semiconductors, software, and custom ASIC solutions for digital video applications. Currently, there is 1 analyst who rates Pixelworks a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PXLW - FREE

TheStreet Quant Ratings rates Pixelworks as a sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. Get the full Pixelworks Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump